Obesity drug developer Aardvark Therapeutics (AARD) has filed for a $100M initial public offering. Aardvark (AARD) didn't disclose any terms in its SEC filing, but indicated in its filing fee ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback